CEO Michael Kauffman sold $282K of Karyopharm Therapeutics Inc.

Sold$281,644

$14.83Price

18,990Shares

−1%Stake

What KPTI did after the filing

Prices for KPTI after this filing aren't in yet.

Traded Thu, Feb 18. Filed Mon, Feb 22, 3:09 PM ET, during the session. Not investment advice.